この新しいレポートでは、新たな検査、技術、計測機器、売上予測、市場シェア、主要サプライヤーの戦略的プロファイルなど、ロシアの治療薬モニタリング検査市場の分析を提供します。
今後10年間で、TDM市場は大きな変革を遂げるでしょう。これらの変化は、新しいより厳格な規制の収束、診断技術、システムエンジニアリング、自動化、ITの進歩、そして競争の激化によって引き起こされます。一部のセグメントは、基礎となる技術よりも製品の位置付けとテストあたりのコストが重要になるコモディティマーケットに似たものになり始めます。この進化する市場は、さまざまな新しい機器、試薬システム、および検体準備装置、制御、キャリブレーターなどの補助製品に刺激的な機会を生み出すでしょう。
このレポートは、現在のサプライヤーと潜在的な市場参入者が新たな機会を特定して評価し、効果的な戦略的対応を開発するのに役立つように設計された、独自の市場と技術の評価です。この調査では、主要なTDMアッセイの5年間の予測、主要な分析装置の特徴の比較、主要な競合他社のプロファイルを提供しています
目次
Table of Contents
Introduction
Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
1. Overview
2. Amikacin
3. Apixaban
4. Argatroban
5. Betrixaban
6. Carbamazepine
7. Cyclosporin
8. Dabigatran
9. Digoxin
10. Edoxaban
11. Everolimus
12. Fluindione
13. Gentamicin
14. Levetiracetam
15. Lithium
16. Methotrexate
17. NAPA/Procainamide
18. Phenobarbital
19. Phenytoin
20. Quinidine
21. Rivaroxaban
22. Sirolimus
23. Tacrolimus
24. Theophylline
25. Tobramycin
26. Topirimate
27. Valproic Acid
28. Vancomycin
29. Warfarin
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alere/Inverness,
Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus,
Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox,
Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
IL/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
List of Tables
Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Tests
Major Companies Developing or Marketing
Biosensors for Genetic Disease Testing
Japan, Laboratories Performing TDM
Tests By Market Segment
Japan, Hospital Laboratories Performing
TDM Tests By Bed Size
Japan, Commercial/Private Laboratories
Performing TDM Tests By Annual Test Volume
Japan, TDM Test Volume Forecast
By Market Segment
Japan, Hospital Laboratories, TDM
Test Volume Forecast by Assay
Japan, Commercial/Private Laboratories,
TDM Test Volume Forecast by Assay
List of Tables (continued)
Japan, TDM Reagent Market Forecast
By Market Segment
Japan, Hospital Laboratories, TDM
Reagent Market Forecast by Assay
Japan, Commercial/Private Laboratories,
TDM Reagent Market Forecast by Assay
Japan, Major Suppliers of Immunodiagnostic Products,
Estimated Market Shares
